U.S. Specialty Stores Stock News

NYSE:IOT
NYSE:IOTSoftware

What Samsara (IOT)'s New Smart Compliance Platform Means For Shareholders

On 21 April 2026, Samsara launched Smart Compliance for EU and UK fleets, unifying tachograph compliance, telematics, and AI-driven safety into a single platform with real-time in-cab alerts and centralized dashboards. By offering integrated rulesets across 17 European countries and proactive pre-infringement audio alerts, the solution aims to cut compliance risk and administrative burdens for cross-border operators. Next, we’ll examine how this Smart Compliance launch, particularly its...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

How Investors May Respond To MercadoLibre (MELI) Doubling Down On Logistics And Banking Integration

In recent months, MercadoLibre reported past quarterly revenue of US$8.76 billion, growing about 44.6% year over year and beating analyst expectations, while simultaneously lowering free-shipping thresholds and expanding its delivery and advertising capabilities amid intensifying Latin American e-commerce competition. At the same time, the company has been pushing deeper into banking services for underbanked customers, a move that could reshape how its commerce, payments, and credit...
NYSE:MOH
NYSE:MOHHealthcare

Molina Healthcare (MOH) Valuation Check After Earnings Beat And Reaffirmed 2026 EPS Guidance

Molina Healthcare (MOH) recently reported first quarter 2026 results that beat earnings expectations, supported by disciplined medical cost management, and reaffirmed its full year adjusted EPS guidance despite lower revenue forecasts and Medicaid membership attrition. See our latest analysis for Molina Healthcare. The strong first quarter earnings beat and reiterated adjusted EPS guidance have been met with a sharp shift in sentiment, with a 31.3% 1 month share price return. This contrasts...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Assessing Kymera Therapeutics (KYMR) Valuation After Fast Track Win For KT-621 And Gilead Deal For KT-200

Kymera Therapeutics (KYMR) is back in focus after the FDA granted Fast Track status to its oral STAT6 degrader KT-621 for eosinophilic asthma, alongside Gilead securing global rights to Kymera’s CDK2 degrader KT-200. See our latest analysis for Kymera Therapeutics. The recent Fast Track news and the KT-200 deal with Gilead come after a strong run, with Kymera’s 30 day share price return of 8.64% and 1 year total shareholder return of 155.29% signaling strong momentum around the pipeline...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation (ONTO) Is Up 5.9% After Rigaku Stake, Dragonfly G5 Win And Guidance Hike

Earlier this month, Onto Innovation Inc. announced a collaboration with X-ray specialist Rigaku Holdings Corporation and a US$710,000,000 minority stake in Rigaku, alongside successful qualification of its Dragonfly G5 platform and raised revenue guidance for the first half of 2026. Together, these moves deepen Onto Innovation’s role in advanced process control and packaging, broadening its toolkit in X-ray metrology and AI-enabled inspection. We’ll now examine how the Rigaku collaboration...
NYSE:SDRL
NYSE:SDRLEnergy Services

Does New Gulf Drillship Backlog From LLOG Deals Change The Bull Case For Seadrill (SDRL)?

Earlier this week, Harbour Energy subsidiary LLOG Exploration Company LLC announced two ultra-deepwater drilling contract awards with Seadrill in the U.S. Gulf, adding about US$260 million to Seadrill’s backlog through extensions for the West Neptune and a new 270-day program for the West Vela starting in 2026. This incremental backlog further secures future utilization for two high-spec drillships, underlining Seadrill’s exposure to longer-duration, higher-value offshore projects in the...
NYSE:BIP
NYSE:BIPIntegrated Utilities

A Look At Brookfield Infrastructure Partners (NYSE:BIP) Valuation As Shares Deliver 31.8% One Year Return

Brookfield Infrastructure Partners overview Brookfield Infrastructure Partners (NYSE:BIP) has drawn investor attention as its units trade around $36.22, with recent returns varying between a small 1 day move and double digit gains over the past year. See our latest analysis for Brookfield Infrastructure Partners. The recent 1 month share price return of 3.9% and year to date share price return of 5.6%, alongside a 1 year total shareholder return of 31.8%, suggest momentum has been building...
NYSE:AVTR
NYSE:AVTRLife Sciences

Avantor Taps Brellier To Steer Bioscience Growth And Transformation Shift

Avantor appointed Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products and Chief Transformation Officer. He will lead growth initiatives in bioscience and medtech while also running Avantor's Revival Management Office. The appointment gives one executive responsibility for both day to day business execution and company wide transformation. For investors tracking NYSE:AVTR, this leadership move lands at a time when the share price is around $7.90 and recent performance...
NasdaqGS:ABNB
NasdaqGS:ABNBHospitality

How Wells Fargo’s Upgrade and Cramer’s Endorsement Will Impact Airbnb (ABNB) Investors

Earlier this week, Wells Fargo upgraded Airbnb’s rating to “Overweight,” citing a potential inflection point supported by initiatives like “Reserve Now, Pay Later” and solid operating metrics. Adding to this, Jim Cramer publicly endorsed the company, highlighting CEO Brian Chesky’s leadership as a key pillar of renewed analyst confidence in Airbnb’s prospects. Next, we’ll explore how Wells Fargo’s upgrade at this potential inflection point could influence Airbnb’s existing investment...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

What Fox (FOXA)'s Expected Q3 EPS Dip And Analyst Optimism Means For Shareholders

Earlier this week, Fox Corporation reported that analysts expect its upcoming third-quarter results to show adjusted EPS of US$1.04, about a 5.5% decline from the prior-year quarter’s US$1.10. Despite this anticipated earnings softness, analysts remain cautiously optimistic on Fox, citing its recent pattern of beating bottom-line estimates and a majority of hold or buy ratings. We’ll now examine how the expected single-digit earnings decline and ongoing analyst optimism may influence Fox’s...
NYSE:QGEN
NYSE:QGENLife Sciences

Is Qiagen’s (QGEN) New Infection and Oncology Tools Quietly Rewiring Its Diagnostics Moat?

In April 2026, QIAGEN N.V. showcased new oncology workflow applications and automation platforms, and expanded its syndromic testing portfolio with a CE-IVDR-certified bloodstream infection panel, underscoring its focus on multi-omics profiling, genomic data interpretation and rapid infectious disease diagnostics. These launches deepen QIAGEN’s integration of sample preparation, high-throughput sequencing, and AI-enabled data interpretation, reinforcing its role in connecting research...
NYSE:PWR
NYSE:PWRConstruction

Should Quanta’s Expanding US$44 Billion Backlog and Higher Earnings Outlook Require Action From Quanta Services (PWR) Investors?

Quanta Services recently reported that, over the past six months, it delivered strong quarterly results and built a backlog of about US$44.00 billion, signaling a substantial pipeline of secured work. Analysts now expect higher near-term revenue and earnings, highlighting Quanta’s track record of topping earnings forecasts and reinforcing confidence in its future profit potential. With expectations for higher quarterly earnings supported by a sizeable backlog, we’ll examine how this affects...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Urban Outfitters (URBN) Valuation Check As Sol De Janeiro Tie Up Expands Beauty And Buyback Story

Sol de Janeiro partnership puts Urban Outfitters’ beauty push in focus Urban Outfitters (URBN) stock is drawing attention after the retailer announced a new lifestyle partnership with Sol de Janeiro, adding more than 40 beauty products across body care, fragrance, and haircare to its assortment. See our latest analysis for Urban Outfitters. Against this backdrop, Urban Outfitters’ share price sits at US$73.64, with a 30-day share price return of 20.31% and a 1-year total shareholder return of...
NYSE:DRI
NYSE:DRIHospitality

A Look At Darden Restaurants (DRI) Valuation After Recent Steady Share Price Performance

Event context and recent stock performance Darden Restaurants (DRI) has drawn fresh attention after a period of relatively steady trading, with the stock returning about 4% over the past month and roughly 2% over the past 3 months. See our latest analysis for Darden Restaurants. Zooming out, Darden’s share price has a year to date return of 7.4%, while the 3 year total shareholder return of 45.9% points to momentum that has built over a longer period. If Darden’s track record in restaurants...
NYSE:EQT
NYSE:EQTOil and Gas

Assessing EQT’s Valuation After Record Free Cash Flow And Earnings Beat

EQT (EQT) shares have been in focus after the company reported first quarter 2026 results that beat market expectations, with record free cash flow, strong revenue and resilient production during Winter Storm Fern. See our latest analysis for EQT. Despite the earnings beat and record free cash flow, the share price has declined 12.8% over the past month from recent highs. However, the year-to-date share price return of 10.2% and 1-year total shareholder return of 18.7% suggest that momentum...
NYSE:MPC
NYSE:MPCOil and Gas

Is Marathon Petroleum (MPC) Still Attractive After A 66.6% One Year Share Price Gain

Wondering if Marathon Petroleum at around US$224 per share still offers value, or if most of the opportunity is already reflected in the price. The stock has returned 4.9% over the last week, while the 30 day return shows an 11.0% decline, set against a year to date return of 35.7% and a 66.6% return over the past year. Recent headlines have focused on Marathon Petroleum's position in the US energy sector and its capital allocation moves. These factors often influence how investors think...
NYSE:FOR
NYSE:FORReal Estate

A Look At Forestar Group's (FOR) Valuation After Quarterly Earnings And Updated Lot Delivery Guidance

Forestar Group (FOR) has drawn fresh attention after reporting second quarter and year to date 2026 results along with updated guidance, reaffirming full year revenue expectations while slightly tightening its target range for residential lot deliveries. See our latest analysis for Forestar Group. The latest earnings update and guidance appear to have supported positive sentiment. A 30 day share price return of 13.34% and a 1 year total shareholder return of 43.18% suggest momentum has been...
NYSE:GLW
NYSE:GLWElectronic

Is It Too Late To Consider Corning (GLW) After Its 304% One Year Surge?

Wondering whether Corning at US$175.89 still offers value after such a strong run, or if the price now reflects too much optimism. The stock has posted returns of 7.0% over the last 7 days, 28.6% over 30 days, 94.0% year to date and 304.1% over the past year, with multi year returns of 471.8% over 3 years and 354.5% over 5 years. Recent coverage has focused on Corning's position within the broader tech sector and its role in key end markets, giving investors more context for these share...
NYSE:ROL
NYSE:ROLCommercial Services

What Rollins (ROL)'s Steady Q1 Results and FTC Noncompete Ruling Mean For Shareholders

Earlier this week, Rollins, Inc. reported first‑quarter 2026 net income of US$107.84 million with flat basic and diluted earnings per share of US$0.22, while also declaring a regular quarterly dividend of US$0.1825 per share payable in June. These updates followed an FTC order requiring Rollins to halt enforcement of noncompete agreements for over 18,000 employees, reshaping its labor and competitive landscape. We’ll now examine how Rollins’ resilient Q1 performance and continued M&A...
NYSE:BDX
NYSE:BDXMedical Equipment

A Look At Becton Dickinson (BDX) Valuation After Recent Share Price Weakness

Setting the scene for Becton Dickinson (BDX) Becton Dickinson (BDX) has been on investors’ radar after a period of weaker share performance, including a return of about negative 25% over the past 3 months and negative 22% year to date. See our latest analysis for Becton Dickinson. With the share price at US$152.14, Becton Dickinson’s recent 7 day share price return of a 4% decline and 3 month share price return of a 25% decline point to fading momentum, while the 1 year total shareholder...
NYSE:GOLF
NYSE:GOLFLeisure

Is It Too Late To Consider Acushnet Holdings (GOLF) After Its Strong 1-Year Rally?

Wondering if Acushnet Holdings at around US$98 per share still offers value, or if most of the opportunity is already reflected in the price. The stock has seen mixed shorter term returns, with a 1.9% decline over the last week, 6.4% over the last month, 19.5% year to date, and 59.9% over the last year. Recent attention on Acushnet Holdings has centered on its position in golf equipment and apparel and how demand trends in the sport relate to its current share price. Investors are weighing...
NasdaqGS:MBX
NasdaqGS:MBXPharmaceuticals

A Look At MBX Biosciences (MBX) Valuation After Its Recent Share Price Move

Understanding the Recent Move in MBX Biosciences MBX Biosciences (MBX) has drawn fresh attention after a recent trading session in which the stock closed at US$31.96, prompting investors to revisit how its clinical pipeline and financial profile align with current expectations. See our latest analysis for MBX Biosciences. While the 1 day share price return of 4.28% and 7 day share price return of 5.36% show recent softness around US$31.96, the 30 day share price return of 12.14% and very...
NYSE:VMC
NYSE:VMCBasic Materials

Is It Too Late To Consider Vulcan Materials (VMC) After Its Strong Multi‑Year Run?

Investors may be wondering whether Vulcan Materials at around US$292 a share is offering good value right now, or if the easy gains are already behind it. The stock has returned 0.1% over the last week, 11.7% over the last month, is roughly flat year to date with a 0.2% decline, and has posted 19.1% over 1 year, 70.6% over 3 years, and 70.5% over 5 years. Recent coverage has focused on Vulcan Materials as a key basic materials name, with attention on how its share price performance compares...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Is It Too Late To Consider Robinhood Markets (HOOD) After Its 71% One Year Surge?

If you are wondering whether Robinhood Markets is priced for more growth or already reflects the story in full, this breakdown may help you frame what the current share price might be implying. The stock last closed at US$84.71, with a 7 day return of a 6.7% decline, a 30 day return of 28.3%, a year to date return of a 26.5% decline, and a 1 year return of 71.3%. Over the past year, Robinhood has remained in the headlines as a platform closely associated with retail trading activity and...